Your browser doesn't support javascript.
loading
: 20 | 50 | 100
1 - 20 de 230
1.
BMC Gastroenterol ; 24(1): 31, 2024 Jan 12.
Article En | MEDLINE | ID: mdl-38216868

BACKGROUND: Rectal cancer is commonly treated by chemoradiation therapy, followed by the low anterior resection anal sphincter-preserving surgery, with a temporary protecting ileostomy. After reversal of the stoma a condition known as low anterior resection syndrome (LARS) can occur characterized by a combination of symptoms such as urgent bowel movements, lack of control over bowel movements, and difficulty fully emptying the bowels. These symptoms have a significant negative impact on the quality of life for individuals who have survived the cancer. Currently, there is limited available data regarding the presence, risk factors, and effects of treatment for these symptoms during long-term follow-up. AIMS: To evaluate long term outcomes of low anterior resection surgery and its correlation to baseline anorectal manometry (ARM) parameters and physiotherapy with anorectal biofeedback (BF) treatment. METHODS: One hundred fifteen patients (74 males, age 63 ± 11) who underwent low anterior resection surgery for rectal cancer were included in the study. Following surgery, patients were managed by surgical and oncologic team, with more symptomatic LARS patients referred for further evaluation and treatment by gastroenterologists. At follow up, patients were contacted and offered participation in a long term follow up by answering symptom severity and quality of life (QOL) questionnaires. RESULTS: 80 (70%) patients agreed to participate in the long term follow up study (median 4 years from stoma reversal, range 1-8). Mean time from surgery to stoma closure was 6 ± 4 months. At long term follow up, mean LARS score was 30 (SD 11), with 55 (69%) patients classified as major LARS (score > 30). Presence of major LARS was associated with longer time from surgery to stoma reversal (6.8 vs. 4.8 months; p = 0.03) and with adjuvant chemotherapy (38% vs. 8%; p = 0.01). Patients initially referred for ARM and BF were more likely to suffer from major LARS at long term follow up (64% vs. 16%, p < 0.001). In the subgroup of patients who underwent perioperative ARM (n = 36), higher maximal squeeze pressure, higher maximal incremental squeeze pressure and higher rectal pressure on push were all associated with better long-term outcomes of QOL parameters (p < 0.05 for all). 21(54%) of patients referred to ARM were treated with BF, but long term outcomes for these patients were not different from those who did not perform BF. CONCLUSIONS: A significant number of patients continue to experience severe symptoms and a decline in their quality of life even 4 years after undergoing low anterior resection surgery. Prolonged time until stoma reversal and adjuvant chemotherapy emerged as the primary risk factors for a negative prognosis. It is important to note that referring patients for anorectal physiology testing alone tended to predict poorer long-term outcomes, indicating the presence of selection bias. However, certain measurable manometric parameters could potentially aid in identifying patients who are at a higher risk of experiencing unfavorable functional outcomes. There is a critical need to enhance current treatment options for this patient group.


Rectal Neoplasms , Male , Humans , Middle Aged , Aged , Rectal Neoplasms/surgery , Rectal Neoplasms/complications , Quality of Life , Follow-Up Studies , Postoperative Complications/etiology , Postoperative Complications/therapy , Syndrome , Rectum/surgery , Risk Factors
2.
Haemophilia ; 24(4): e207-e212, 2018 Jul.
Article En | MEDLINE | ID: mdl-29877601

INTRODUCTION: Blood group O is known to be associated with lower levels of von Willebrand factor (VWF) and with increased bleeding complications. The influence of blood group O on postpartum blood loss was assessed by a few studies, however, without adjustment for important obstetric risk factors for postpartum blood loss. AIM: Aim of this study was to investigate whether women with blood group O exhibit increased blood loss after delivery in consideration of established risk factors for postpartum bleeding. METHODS: A total of 1487 patients were prospectively included into this cohort study. Blood loss was assessed by estimated blood loss (in mL), and drop of haemoglobin (Δ haemoglobin) was calculated. Association of blood loss with risk factors (such as blood group O, cervical tears, morbidly adherent placenta, placenta praevia and uterine atony amongst others) was assessed with appropriate tests. Significant variables were entered into a stepwise multivariate regression analysis. RESULTS: Women with blood group O showed a significantly higher blood loss when compared to women with blood group non-O (529.2 mL ± 380.4 mL and 490.5 mL ± 276.4 mL, respectively, P = .024)). The increased blood loss in women with blood group O remained significant after multivariate regression analysis (difference 47 mL, P = .019). CONCLUSION: This is the first study reporting significantly increased blood loss following delivery in women with blood group O after adjustment for major risk factors for postpartum blood loss. Albeit having a statistically significant, but clinically minor effect on absolute blood loss, blood group O carriers may suffer from aggravated bleeding in the presence of additional obstetric bleeding pathologies.


ABO Blood-Group System , Postpartum Hemorrhage/blood , Adult , Female , Hemoglobins/metabolism , Humans , Labor, Obstetric , Pregnancy , Risk Factors
3.
Int J Parasitol Drugs Drug Resist ; 8(2): 159-164, 2018 08.
Article En | MEDLINE | ID: mdl-29587237

Trypanosoma congolense is a protozoan parasite that is transmitted by tsetse flies, causing African Animal Trypanosomiasis, also known as Nagana, in sub-Saharan Africa. Nagana is a fatal disease of livestock that causes severe economic losses. Two drugs are available, diminazene and isometamidium, yet successful treatment is jeopardized by drug resistant T. congolense. Isothermal microcalorimetry is a highly sensitive tool that can be used to study growth of the extracellular T. congolense parasites or to study parasite growth inhibition after the addition of antitrypanosomal drugs. Time of drug action and time to kill can be quantified in a simple way by real time heat flow measurements. We established a robust protocol for the microcalorimetric studies of T. congolense and developed mathematical computations in R to calculate different parameters related to growth and the kinetics of drug action. We demonstrate the feasibility and benefit of the method exemplary with the two standard drugs, diminazene aceturate and isometamidium chloride. The method and the mathematical approach can be translated to study other pathogenic or non-pathogenic cells if they are metabolically active and grow under axenic conditions.


Antiprotozoal Agents/pharmacology , Calorimetry/methods , Temperature , Trypanocidal Agents/pharmacology , Trypanosoma congolense/drug effects , Trypanosoma congolense/growth & development , Animals , Axenic Culture , Cattle , Computer Systems , Diminazene/analogs & derivatives , Diminazene/pharmacology , Drug Discovery , Drug Resistance , Models, Theoretical , Phenanthridines/pharmacology , Trypanosoma congolense/physiology , Trypanosomiasis, Bovine/diagnosis , Trypanosomiasis, Bovine/parasitology
4.
Article En | MEDLINE | ID: mdl-29203485

Therapies for human African trypanosomiasis and Chagas disease, caused by Trypanosoma brucei and Trypanosoma cruzi, respectively, are limited, providing minimal therapeutic options for the millions of individuals living in very poor communities. Here the effects of 10 novel quinolines are evaluated in silico and by phenotypic studies using in vitro and in vivo models. Absorption, distribution, metabolism, excretion, and toxicity (ADMET) properties revealed that most molecules did not infringe on Lipinski's rules, which is a prediction of good oral absorption. These quinolines showed high probabilities of Caco2 permeability and human intestinal absorption and low probabilities of mutagenicity and of hERG1 inhibition. In vitro screens against bloodstream forms of T. cruzi demonstrated that all quinolines were more active than the reference drug (benznidazole [Bz]), except for DB2171 and DB2192, with five (DB2187, DB2131, DB2186, DB2191, and DB2217) displaying 50% effective concentrations (EC50s) of <3 µM (4-fold lower than that of Bz). Nine quinolines were more effective than Bz (2.7 µM) against amastigotes, showing EC50s ranging from 0.6 to 0.1 µM. All quinolines were also highly active in vitro against African trypanosomes, showing EC50s of ≤0.25 µM. The most potent and highly selective candidates for each parasite species were tested in in vivo models. Results for DB2186 were promising in mice with T. cruzi and T. brucei infections, reaching a 70% reduction of the parasitemia load for T. cruzi, and it cured 2 out of 4 mice infected with T. brucei DB2217 was also active in vivo and cured all 4 mice (100% cure rate) with T. brucei infection.


Chagas Disease/drug therapy , Quinolines/pharmacology , Trypanocidal Agents/pharmacology , Trypanosoma brucei brucei/drug effects , Trypanosoma cruzi/drug effects , Animals , Caco-2 Cells , Cell Line , Cell Line, Tumor , Female , Humans , Male , Mammals , Mice , Parasitemia/drug therapy , Rats
5.
Neurogastroenterol Motil ; 30(5): e13268, 2018 05.
Article En | MEDLINE | ID: mdl-29250864

BACKGROUND: Small bowel fed response is an increased contractile activity pattern following the ingestion of a meal. Postprandial motility is traditionally evaluated using small bowel manometry. Wireless motility capsule (WMC) is an ingestible wireless capsule that measures pH, temperature, and intraluminal pressure. The primary aim of the study was to assess small bowel fed response captured with the non-invasive WMC. The secondary aim was to compare the fed response patterns between healthy subjects and patients with motility disorders of gastroparesis and constipation. METHODS: All subjects had 250 cc Ensure® meal 6 hours after WMC ingestion. Frequency of contractions (Ct), area under the curve (AUC), and motility index (MI) were analyzed during 30 minutes of pre-prandial baseline and 60 minutes postprandially in 20-minute windows. KEY RESULTS: One hundred and eighty-eight subjects (107 healthy, 23 gastroparetics, 58 constipated) were analyzed. Healthy: Ct, AUC, and MI all increased significantly immediately after meal ingestion (P < .01). Motility parameters peak at 20-40 minutes postmeal. The motor activity decreased at the end of postprandial hour, but was still significantly higher than the fasting baseline (P < .01). Gastroparetics: All motility parameters failed to increase significantly compared to the baseline throughout the entire postprandial hour. Constipated: The fed response was similar to healthy subjects. CONCLUSIONS AND INFERENCES: The small bowel fed response was readily observed in healthy and chronic constipation subjects with WMC but is blunted in gastroparetics. A blunted small bowel fed response suggests neuropathic changes outside the stomach and may contribute to postprandial symptoms.


Constipation/physiopathology , Gastrointestinal Motility/physiology , Gastroparesis/physiopathology , Intestine, Small/physiopathology , Postprandial Period/physiology , Adult , Capsule Endoscopy , Female , Healthy Volunteers , Humans , Male , Middle Aged , Muscle Contraction/physiology
6.
Rev Esp Sanid Penit ; 16(2): 29-37, 2014.
Article Es | MEDLINE | ID: mdl-25072787

OBJECTIVE: To obtain data on substance abuse and mental disorders amongst a population of inmates imprisoned for gender violence. DESIGN: 106 intimate partner violence offenders were recruited in our study, all of whom were prison inmates. The study is descriptive and statistical comparison of percentages was used. RESULTS: the percentage of substance abuse was 61.3%; most of which consisted of alcohol and cocaine. According to DSM-IV R, 25.5% of the inmates had at least one psychiatric diagnosis at the time when entering prison: 11.3% adjustment disorder with depressed mood, 6.6% personality disorders, 2.8% psychosis, 1.9% major depressive disorder, 1.9% bipolar disorder and 1.9% psycho-organic disorder were encountered. The average age of the men of the sample was forty years old. The most common nationality was Spanish. The percentage of immigrants was significant greater than the global percentage of the general population. The percentage of global substance consumption and psychopathologic problems is greater than data obtained in IPV from other populations, like samples of men charged by their partners with gender violence. CONCLUSIONS: depressive symptoms, personality disorders, alcohol and cocaine consumption need to be investigated as gender violence risk markers in Spain. Attention should be paid to the role of consumption prevention when entering prison.


Intimate Partner Violence , Mental Disorders/epidemiology , Prisoners , Substance-Related Disorders/epidemiology , Adult , Aged , Aged, 80 and over , Humans , Male , Middle Aged , Prisons , Young Adult
7.
Rev. esp. sanid. penit ; 16(2): 29-37, 2014. graf, tab
Article Es | IBECS | ID: ibc-124001

Objetivos: obtención de datos epidemológicos sobre consumo de sustancias y trastornos mentales en agresores de género. Material y Método: estudio descriptivo sobre una muestra de 106 varones ingresados en prisión por violencia de género. Estimación de porcentajes de consumo perjudicial de sustancias y de diagnósticos psiquiátricos al ingreso en prisión con uso de la historia clínica informatizada del Servicio Navarro de Salud. Resultados: el 61’3% realizan un consumo perjudicial de sustancias. El porcentaje es mayor que en otros estudios realizados sobre poblaciones de agresores denunciados y detenidos. Las sustancias mayormente implicadas son alcohol y cocaína. Al ingreso en prisión, el 25’5% de los agresores tiene, al menos, un diagnóstico psiquiátrico. Destacan los trastornos adaptativos con un 11’3%, los trastornos de personalidad con un 6’6%, un 2’8% de trastornos psicóticos, un 1’9% de trastornos depresivos endógenos, un 1’9% de trastornos bipolares y un 1’9% de trastornos psico-orgánicos. El porcentaje de trastornos psicopatológicos es mayor que en otros estudios realizados sobre agresores. La media de edad de los individuos fue de 40 años. La nacionalidad con porcentaje mayoritario ha sido la española con un 50%. El porcentaje de inmigrantes es significativamente superior al de la población general. Conclusiones: Existe interés en investigar síntomas depresivos, rasgos patológicos de personalidad y consumo de alcohol y cocaína como desencadenante de episodios de violencia de género. El resultado sugiere interés en investigar el valor preventivo de medidas de seguridad específicas en consumo de sustancias frente a medidas de ingreso en prisión (AU)


Objective: To obtain data on substance abuse and mental disorders amongst a population of inmates imprisoned for gender violence. Design: 106 intimate partner violence offenders were recruited in our study, all of whom were prison inmates. The study is descriptive and statistical comparison of percentages was used. Results: the percentage of substance abuse was 61.3%; most of which consisted of alcohol and cocaine. According to DSM-IV R, 25.5% of the inmates had at least one psychiatric diagnosis at the time when entering prison: 11.3% adjustment disorder with depressed mood, 6.6% personality disorders, 2.8% psychosis, 1.9% major depressive disorder, 1.9% bipolar disorder and 1.9% psycho-organic disorder were encountered. The average age of the men of the sample was forty years old. The most common nationality was Spanish. The percentage of immigrants was significant greater than the global percentage of the general population. The percentage of global substance consumption and psychopathologic problems is greater than data obtained in IPV from other populations, like samples of men charged by their partners with gender violence. Conclusions: depressive symptoms, personality disorders, alcohol and cocaine consumption need to be investigated as gender violence risk markers in Spain. Attention should be paid to the role of consumption prevention when entering prison (AU)


Humans , Male , Substance-Related Disorders/epidemiology , Violence Against Women , Mental Disorders/epidemiology , Prisoners/statistics & numerical data , Criminals/statistics & numerical data , Epidemiology, Descriptive , Spouse Abuse/statistics & numerical data , Domestic Violence/statistics & numerical data , Risk Factors , Emigrants and Immigrants/statistics & numerical data
8.
J Ethnopharmacol ; 147(1): 220-3, 2013 May 02.
Article En | MEDLINE | ID: mdl-23501156

ETHNOPHARMACOLOGICAL RELEVANCE: Khaya species, endemic to Africa and Madagascar, continues to be valuable in indigenous traditional medicine. Their bitter tasting barks are decocted to treat fevers, several febrile conditions, microbial infections and worm infestations. In the Budongo rain forest of Western Uganda, non-human primates, especially chimpanzees and baboons, have been observed to eat the bitter non-nutritious bark and occasionally the seed. MATERIALS AND METHODS: Extracts were prepared by sequential fractionation with solvents of increasing polarities and assayed using standard procedures. Bioassay guided purification of the petroleum ether extract by column chromatography yielded three pure limonoids, Grandifolione (1), 7-deacetylkhivorin (2) and 1,3-deacetyldeoxyhavenensin (3). The antitrypanosomal, antileishmanial and antiplasmodial activities of pure compounds (1) and (2) were evaluated in vitro against Plasmodium falciparum K1, Trypanosoma brucei rhodesiense STIB 900, Trypanosoma cruzi trypomastigotes (Tulahuen C4), and axenic Leishmania donovani MHOMET-67/L82 and for cytotoxicity against L6 rat skeletal myoblast cells, in parallel with standard drugs. RESULTS: Of the four extracts tested, the petroleum ether extract showed activity against Plasmodium falciparum (IC50 0.955 µg/ml) and Trypanosoma brucei rhodesiense (IC50 5.72 µg/ml). The pure compounds (1) and (2) demonstrated activity against Plasmodium falciparum (KI strain) and marginal activities against Trypanosoma brucei brucei, Trypanosoma brucei rhodesiense, Trypanosoma cruzi and Leishmania donovani. CONCLUSION: The present study provides evidence justifying the use of Khaya preparations in traditional medicine to treat fevers and microbial infections. The observed antiprotozoal activity of grandifolione and 7-deacetylkhivorin from the seed of Khaya anthotheca further confirms the ethnomedicinal potential of this plant and supports the hypothesis that non-human hominids (chimpanzees and baboons) too, eat the bitter bark and seeds for self-medication and in general, the use of Khaya plant material for medication by humans in disease endemic tropical areas. The antiprotozoal activity of gradifolione, and, the antitrypanosomal and antileishmanial activities of 7-deacetylkhivorin are reported here for the first time.


Antiprotozoal Agents/pharmacology , Behavior, Animal , Meliaceae , Pan troglodytes , Animals , Antimalarials/pharmacology , Antiprotozoal Agents/chemistry , Antiprotozoal Agents/isolation & purification , Antiprotozoal Agents/toxicity , Biological Assay , Cell Line , Cell Survival/drug effects , Chemical Fractionation , Chromatography , Inhibitory Concentration 50 , Leishmania donovani/drug effects , Meliaceae/chemistry , Myoblasts, Skeletal/drug effects , Myoblasts, Skeletal/pathology , Parasitic Sensitivity Tests , Phytotherapy , Plant Bark , Plants, Medicinal , Plasmodium falciparum/drug effects , Rats , Seeds , Solvents/chemistry , Trypanocidal Agents/pharmacology , Trypanosoma brucei rhodesiense/drug effects , Trypanosoma cruzi/drug effects
9.
Curr Med Chem ; 19(14): 2176-228, 2012.
Article En | MEDLINE | ID: mdl-22414104

Infections with protozoan parasites are a major cause of disease and mortality in many tropical countries of the world. Diseases caused by species of the genera Trypanosoma (Human African Trypanosomiasis and Chagas Disease) and Leishmania (various forms of Leishmaniasis) are among the seventeen "Neglected Tropical Diseases" (NTDs) defined by the WHO. Furthermore, malaria (caused by various Plasmodium species) can be considered a neglected disease in certain countries and with regard to availability and affordability of the antimalarials. Living organisms, especially plants, provide an innumerable number of molecules with potential for the treatment of many serious diseases. The current review attempts to give an overview on the potential of such plant-derived natural products as antiprotozoal leads and/or drugs in the fight against NTDs. In part I, a general description of the diseases, the current state of therapy and need for new therapeuticals, assay methods and strategies applied in the search for new plant derived natural products against these diseases and an overview on natural products of terpenoid origin with antiprotozoal potential were given. The present part II compiles the current knowledge on natural products with antiprotozoal activity that are derived from the shikimate pathway (lignans, coumarins, caffeic acid derivatives), quinones of various structural classes, compounds formed via the polyketide pathways (flavonoids and related compounds, chromenes and related benzopyrans and benzofurans, xanthones, acetogenins from Annonaceae and polyacetylenes) as well as the diverse classes of alkaloids. In total, both parts compile the literature on almost 900 different plant-derived natural products and their activity data, taken from over 800 references. These data, as the result of enormous efforts of numerous research groups world-wide, illustrate that plant secondary metabolites represent an immensely rich source of chemical diversity with an extremely high potential to yield a wealth of lead structures towards new therapies for NTDs. Only a small percentage, however, of the roughly 200,000 plant species on earth have been studied chemically and only a small percentage of these plants or their constituents has been investigated for antiprotozoal activity. The repository of plant-derived natural products hence deserves to be investigated even more intensely than it has been up to present.


Antiprotozoal Agents/therapeutic use , Biological Products/therapeutic use , Neglected Diseases/drug therapy , Plant Extracts/therapeutic use , Plants, Medicinal/chemistry , Protozoan Infections/drug therapy , Animals , Antiprotozoal Agents/chemistry , Antiprotozoal Agents/metabolism , Biological Products/chemistry , Biological Products/metabolism , Humans , Phytotherapy , Plant Extracts/chemistry , Plant Extracts/metabolism , Plants, Medicinal/metabolism
10.
Curr Med Chem ; 19(14): 2128-75, 2012.
Article En | MEDLINE | ID: mdl-22414103

Infections with protozoan parasites are a major cause of disease and mortality in many tropical countries of the world. Diseases caused by species of the genera Trypanosoma (Human African Trypanosomiasis and Chagas Disease) and Leishmania (various forms of Leishmaniasis) are among the seventeen "Neglected Tropical Diseases" (NTDs) defined as such by WHO due to the neglect of financial investment into research and development of new drugs by a large part of pharmaceutical industry and neglect of public awareness in high income countries. Another major tropical protozoan disease is malaria (caused by various Plasmodium species), which -although not mentioned currently by the WHO as a neglected disease- still represents a major problem, especially to people living under poor circumstances in tropical countries. Malaria causes by far the highest number of deaths of all protozoan infections and is often (as in this review) included in the NTDs. The mentioned diseases threaten many millions of lives world-wide and they are mostly associated with poor socioeconomic and hygienic environment. Existing therapies suffer from various shortcomings, namely, a high degree of toxicity and unwanted effects, lack of availability and/or problematic application under the life conditions of affected populations. Development of new, safe and affordable drugs is therefore an urgent need. Nature has provided an innumerable number of drugs for the treatment of many serious diseases. Among the natural sources for new bioactive chemicals, plants are still predominant. Their secondary metabolism yields an immeasurable wealth of chemical structures which has been and will continue to be a source of new drugs, directly in their native form and after optimization by synthetic medicinal chemistry. The current review, published in two parts, attempts to give an overview on the potential of such plant-derived natural products as antiprotozoal leads and/or drugs in the fight against NTDs.


Antiprotozoal Agents/therapeutic use , Biological Products/therapeutic use , Neglected Diseases/drug therapy , Plant Extracts/therapeutic use , Plants, Medicinal/chemistry , Plants, Medicinal/metabolism , Protozoan Infections/drug therapy , Animals , Antiprotozoal Agents/chemistry , Antiprotozoal Agents/metabolism , Biological Products/chemistry , Biological Products/metabolism , Humans , Phytotherapy , Plant Extracts/chemistry , Plant Extracts/metabolism
11.
Neurogastroenterol Motil ; 24(4): 332-e165, 2012 Apr.
Article En | MEDLINE | ID: mdl-22292793

BACKGROUND: Assessment of phase III MMC is often not performed due to the invasive nature of antroduodenal manometry used to detect it. The aim of the study was to evaluate the ability of wireless motility capsule (WMC) to detect phase III MMC and correlate it with the simultaneous measurements by antroduodenal manometry (ADM). METHODS: Eighteen patients underwent simultaneous ADM and WMC. MMCs were identified first on ADM and then correlated with WMC events occurring simultaneously. Frequency of contractions per min, AUC, MI, and criteria for amplitude thresholds of contractions representing MCCs on WMC tracings were defined. KEY RESULTS: In 18 patients, a total of 29 MMCs were recorded by ADM. WMC detected 86% of MMC events measured by ADM. Hundred percent (10/10) of MMCs in stomach were detected by WMC, whereas 79% (15/19) of MMCs were detected in SB. The sensitivity and specificity of WMC high amplitude contractions to represent phase III MMC were 90% and 71.8% in the stomach; 73.7% and 84.7% in SB, respectively, and negative predictive value was 99.9% in both regions. CONCLUSIONS & INFERENCES: Wireless motility capsule was able to detect the phase III MMCs as the high amplitude contractions with good fidelity. WMC does not detect the propagation of MMC. Using the pressure thresholds, WMC can detect high amplitude contraction representing phase III MMC with favorable sensitivity/specificity profile and 99.9% negative predictive value. This observation may have clinical significance, as the absence of high amplitude contractions recorded by WMC during fasting state suggests absence of MMCs.


Manometry/instrumentation , Manometry/methods , Myoelectric Complex, Migrating/physiology , Robotics/instrumentation , Robotics/methods , Adult , Capsules , Female , Humans , Intestine, Small/physiology , Male , Stomach/physiology
12.
Curr Med Chem ; 19: 2128-2175, 2012.
Article En | LILACS, SES-SP, SESSP-IALPROD, SES-SP, SESSP-IALACERVO | ID: biblio-1022985

Infections with protozoan parasites are a major cause of disease and mortality in many tropical countries of the world. Diseases caused by species of the genera Trypanosoma (Human African Trypanosomiasis and Chagas Disease) and Leishmania (various forms of Leishmaniasis) are among the seventeen "Neglected Tropical Diseases" (NTDs) defined as such by WHO due to the neglect of financial investment into research and development of new drugs by a large part of pharmaceutical industry and neglect of public awareness in high income countries. Another major tropical protozoan disease is malaria (caused by various Plasmodium species), which -although not mentioned currently by the WHO as a neglected disease- still represents a major problem, especially to people living under poor circumstances in tropical countries. Malaria causes by far the highest number of deaths of all protozoan infections and is often (as in this review) included in the NTDs. The mentioned diseases threaten many millions of lives world-wide and they are mostly associated with poor socioeconomic and hygienic environment. Existing therapies suffer from various shortcomings, namely, a high degree of toxicity and unwanted effects, lack of availability and/or problematic application under the life conditions of affected populations. Development of new, safe and affordable drugs is therefore an urgent need. Nature has provided an innumerable number of drugs for the treatment of many serious diseases. Among the natural sources for new bioactive chemicals, plants are still predominant. Their secondary metabolism yields an immeasurable wealth of chemical structures which has been and will continue to be a source of new drugs, directly in their native form and after optimization by synthetic medicinal chemistry. The current review, published in two parts, attempts to give an overview on the potential of such plant-derived natural products as antiprotozoal leads and/or drugs in the fight against NTDs.


Plants, Medicinal/metabolism , Plants, Medicinal/chemistry , Protozoan Infections/drug therapy , Biological Products/metabolism , Biological Products/therapeutic use , Biological Products/chemistry , Humans , Plant Extracts/metabolism , Plant Extracts/therapeutic use , Plant Extracts/chemistry , Animals , Phytotherapy , Antiprotozoal Agents/metabolism , Antiprotozoal Agents/therapeutic use , Antiprotozoal Agents/chemistry
13.
J Comp Pathol ; 142(2-3): 95-108, 2010.
Article En | MEDLINE | ID: mdl-19818448

Four hundred bovine urothelial tumours and tumour-like lesions were classified in accordance with the 2004 World Health Organization (WHO) morphological classification for human urothelial tumours. The spectrum of neoplastic lesions of the urinary bladder of cattle is becoming wider and bovine urothelial tumours share striking morphological features with their human counterparts. A classification system based on the WHO scheme would also be appropriate for the classification of bovine bladder tumours. Bovine urothelial tumours are most often multiple. Four distinct growth patterns of bovine urothelial tumours and tumour-like lesions are recognized: flat, exophytic or papillary, endophytic and invasive. Carcinoma in situ (CIS) is the most common flat urothelial lesion, accounting for approximately 4% of urothelial tumours. CIS is detected adjacent to papillary and invasive tumours in 80-90% of cases. Approximately 3% of papillary lesions are papillomas and approximately 5% are 'papillary urothelial neoplasms of low malignant potential' (PUNLMP). Low-grade carcinoma is the most common urothelial tumour of cattle. High-grade carcinomas, and low and high-grade invasive tumours, are less commonly seen. Bovine papillomavirus (BPV) infection and ingestion of bracken fern both play a central role in carcinogenesis of these lesions.


Carcinoma in Situ/veterinary , Carcinoma, Papillary/veterinary , Cattle Diseases , Papilloma/veterinary , Urinary Bladder Neoplasms/veterinary , Urothelium/pathology , Animals , Carcinoma in Situ/pathology , Carcinoma, Papillary/pathology , Cattle , Papilloma/pathology , Urinary Bladder Neoplasms/pathology
14.
J Comp Pathol ; 142(1): 9-18, 2010 Jan.
Article En | MEDLINE | ID: mdl-19596355

The up-regulation of ferritin heavy chain (FHC) is reported in six papillary and in four invasive urothelial tumours of the urinary bladder of cattle grazing on mountain pastures rich in bracken fern. All tumours contained sequence of bovine papillomavirus type-2 (BPV-2) as determined by polymerase chain reaction (PCR) analyses and validated by direct sequencing of the amplified products. The oncoprotein E5 was also detected in these tumours by immunoprecipitation and by immunofluorescence and laser scanning confocal microscopy. Expression of FHC was evaluated by western blot analysis, reverse transcriptase (RT) PCR, real-time RT-PCR and immunohistochemistry. The oligonucleotide sequence of the bovine ferritin amplicons was identical to that of human ferritin. Nuclear overexpression of p65, an important component of nuclear factor kappaB (NF-kappaB) transcription factors, was also observed. These findings suggest that FHC up-regulation may be mediated by activation of NF-kappaB and that in turn this may be related to the resistance of bovine papillomavirus type-2 (BPV-2) infected urothelial cells to apoptosis.


Cattle Diseases/metabolism , Ferritins/metabolism , Papillomavirus Infections/metabolism , Papillomavirus Infections/veterinary , Urinary Bladder Neoplasms/metabolism , Urinary Bladder Neoplasms/veterinary , Animals , Base Sequence , Blotting, Western , Cattle , Cattle Diseases/virology , Electrophoretic Mobility Shift Assay , Ferritins/genetics , Fluorescent Antibody Technique , Humans , Immunoprecipitation , Microscopy, Confocal , Molecular Sequence Data , NF-kappa B/biosynthesis , Papillomavirus Infections/complications , Reverse Transcriptase Polymerase Chain Reaction , Sequence Homology, Nucleic Acid , Up-Regulation , Urinary Bladder Neoplasms/virology
15.
J Comp Pathol ; 142(1): 19-26, 2010 Jan.
Article En | MEDLINE | ID: mdl-19631333

The expression of sigma-2 receptors was investigated in nine urothelial tumours of the urinary bladder of cattle. Each tumour was associated with the presence of DNA of bovine papillomavirus type-2 (BPV-2) and expression of the E5 viral oncoprotein. Five tumours were classified as low-grade carcinoma on the basis of morphological criteria and calculation of mean nuclear area (MNA) and mean nuclear perimeter (MNP). Four tumours were classified as high-grade carcinoma. Sigma-2 receptors were overexpressed in both types of carcinoma. In control normal bovine bladder tissue the density of receptors (expressed as the B(max)) was 0.37 pmol/mg of protein. Low-grade carcinomas had a mean B(max) of 1.37+/-0.32 pmol/mg of protein (range 1.03-1.86) and in high-grade carcinomas the mean B(max) was 10.9+/-2.8 pmol/mg of protein (range 8.2-14). The difference in B(max) between low- and high-grade carcinomas was statistically significant (P=0.0001).


Carcinoma/metabolism , Carcinoma/veterinary , Cattle Diseases/metabolism , Papillomavirus Infections/therapy , Receptors, sigma/biosynthesis , Urinary Bladder Neoplasms/metabolism , Urinary Bladder Neoplasms/veterinary , Animals , Carcinoma/virology , Cattle , Cattle Diseases/virology , DNA, Viral/analysis , Immunoprecipitation , Oncogene Proteins, Viral/biosynthesis , Papillomavirus Infections/complications , Papillomavirus Infections/metabolism , Papillomavirus Infections/veterinary , Polymerase Chain Reaction , Urinary Bladder Neoplasms/virology
16.
Med Chem ; 5(4): 392-7, 2009 Jul.
Article En | MEDLINE | ID: mdl-19689398

A series of thirteen new megazol derivatives, designed exploring the molecular hybridization approach between megazol (3) and heterocombretastatins (2), was synthesized. These new compounds were tested for in vitro antiparasitic activity upon axenic amastigotes of Leishmania donovani. Biological results led us to identify a new potent megazol derivative (4g), which presents an IC(50) = 0.081microg/mL, more active tham the reference drug miltefosine (IC(50) = 0.131microg/mL).


Antiprotozoal Agents/chemistry , Antiprotozoal Agents/pharmacology , Leishmania/drug effects , Thiadiazoles/chemistry , Thiadiazoles/pharmacology , Animals , Antiprotozoal Agents/chemical synthesis , Antiprotozoal Agents/toxicity , Bibenzyls/chemistry , Cell Line , Drug Design , Inhibitory Concentration 50 , Rats , Sulfones/chemistry , Thiadiazoles/chemical synthesis , Thiadiazoles/toxicity
17.
Exp Parasitol ; 122(3): 196-202, 2009 Jul.
Article En | MEDLINE | ID: mdl-19318094

We have selected piperaquine (PQ) and lumefantrine (LM) resistant Plasmodium berghei ANKA parasite lines in mice by drug pressure. Effective doses that reduce parasitaemia by 90% (ED(90)) of PQ and LM against the parent line were 3.52 and 3.93 mg/kg, respectively. After drug pressure (more than 27 passages), the selected parasite lines had PQ and LM resistance indexes (I(90)) [ED(90) of resistant line/ED(90) of parent line] of 68.86 and 63.55, respectively. After growing them in the absence of drug for 10 passages and cryo-preserving them at -80 degrees C for at least 2 months, the resistance phenotypes remained stable. Cross-resistance studies showed that the PQ-resistant line was highly resistant to LM, while the LM-resistant line remained sensitive to PQ. Thus, if the mechanism of resistance is similar in P. berghei and Plasmodium falciparum, the use of LM (as part of Coartem) should not select for PQ resistance.


Antimalarials/pharmacology , Drug Resistance/physiology , Ethanolamines/pharmacology , Fluorenes/pharmacology , Plasmodium berghei/drug effects , Quinolines/pharmacology , Amodiaquine/pharmacology , Amodiaquine/therapeutic use , Animals , Antimalarials/therapeutic use , Artemisinins/pharmacology , Artemisinins/therapeutic use , Chloroquine/pharmacology , Chloroquine/therapeutic use , Disease Models, Animal , Ethanolamines/therapeutic use , Female , Fluorenes/therapeutic use , Lumefantrine , Malaria/drug therapy , Malaria/parasitology , Male , Mice , Parasitemia/drug therapy , Parasitemia/parasitology , Quinolines/therapeutic use , Serial Passage/methods
18.
Antimicrob Agents Chemother ; 53(3): 953-7, 2009 Mar.
Article En | MEDLINE | ID: mdl-19064893

Owing to the lack of oral drugs for human African trypanosomiasis, patients have to be hospitalized for 10 to 30 days to facilitate treatment with parenterally administered medicines. The efficacy of a novel orally administered prodrug, 2,5-bis(4-amidinophenyl)-furan-bis-O-methlylamidoxime (pafuramidine, DB289), was tested in the vervet monkey (Chlorocebus [Cercopithecus] aethiops) model of sleeping sickness. Five groups of three animals each were infected intravenously with 10(4) Trypanosoma brucei rhodesiense KETRI 2537 cells. On the seventh day postinfection (p.i.) in an early-stage infection, animals in groups 1, 2, and 3 were treated orally with pafuramidine at dose rates of 1, 3, or 10 mg/kg of body weight, respectively, for five consecutive days. The animals in groups 4 and 5 were treated with 10 mg/kg for 10 consecutive days starting on the 14th day p.i. (group 4) or on the 28th day p.i. (group 5), when these animals were in the late stage of the disease. In the groups treated in the early stage, 10 mg/kg of pafuramidine completely cured all three monkeys, whereas lower doses of 3 mg/kg and 1 mg/kg cured only one of three and zero of three monkeys, respectively. Treatment of late-stage infections resulted in cure rates of one of three (group 4) and zero of three (group 5) monkeys. These studies demonstrated that pafuramidine was orally active in monkeys with early-stage T. brucei rhodesiense infections at dose rates above 3 mg/kg for 5 days. It was also evident that the drug attained only minimal efficacy against late-stage infections, indicating the limited ability of the molecule to cross the blood-brain barrier. This study has shown that oral diamidines have potential for the treatment of early-stage sleeping sickness.


Benzamidines/therapeutic use , Pentamidine/therapeutic use , Prodrugs/therapeutic use , Trypanocidal Agents/therapeutic use , Trypanosoma brucei rhodesiense/drug effects , Trypanosomiasis, African/drug therapy , Administration, Oral , Animals , Benzamidines/administration & dosage , Chlorocebus aethiops , Disease Models, Animal , Dose-Response Relationship, Drug , Female , Male , Pentamidine/administration & dosage , Prodrugs/administration & dosage , Random Allocation , Time Factors , Treatment Outcome , Trypanocidal Agents/administration & dosage
19.
Tanzan J Health Res ; 11(4): 226-34, 2009 Oct.
Article En | MEDLINE | ID: mdl-20734703

The antiplasmodial, anti-trypanosomal and anti-leishmanial activity of 25 plant extracts obtained from seven Tanzanian medicinal plants: Annickia (Enantia) kummeriae (Annonaceae), Artemisia annua (Asteraceae), Pseudospondias microcarpa (Anacardiaceae), Drypetes natalensis (Euphorbiaceae), Acridocarpus chloropterus (Malpighiaceae), Maytenus senegalensis (Celastraceae) and Neurautanenia mitis (Papilonaceae), were evaluated in vitro against Plasmodium falciparum K1, Trypanosoma brucei rhodesiense STIB 900 and axenic Leishmania donovani MHOM-ET-67/82. Out of the 25 extracts tested, 17 showed good antiplasmodial activity (IC50 0.04-5.0 microg/ml), 7 exhibited moderate anti-trypanosomal activity (IC50 2.3-2.8 microg/ml), while 5 displayed mild anti-leishmanial activity (IC50 8.8-9.79 microg/ml). A. kummeriae, A. annua, P. microcarpa, D. natalensis, M. senegalensis and N. mitis extracts had good antiplasmodial activity (IC50 0.04-2.1 microg/ml) and selectivity indices (29.2-2,250 microg/ml). The high antiplasmodial, moderate anti-trypanosomal and mild anti-leishmanial activity make these plants good candidates for bioassay-guided isolation of anti-protozoal compounds which could serve as new lead structures for drug development.


Leishmania donovani/drug effects , Lethal Dose 50 , Plant Extracts/pharmacology , Plasmodium falciparum/drug effects , Trypanosoma brucei rhodesiense/drug effects , Animals , Inhibitory Concentration 50 , Plant Leaves , Plant Roots , Plants, Medicinal/chemistry , Tanzania
20.
Acta Trop ; 108(1): 6-10, 2008 Oct.
Article En | MEDLINE | ID: mdl-18722336

The choice of drugs for the treatment of sleeping sickness is extremely limited. To redress this situation, the recently synthesised diamidine, 2,5-bis(4-amidinophenyl)-furan (DB75, furamidine) and its methamidoxime prodrug, 2,5-bis(4-amidinophenyl)-furan-bis-O-methylamidoxime (DB289, pafuramidine) were, together with pentamidine, evaluated for efficacy in acute rodent models. The activity was compared in three common mouse models that mimic the first stage of human African trypanosomiasis. The mice were infected with the pleomorphic T .b. rhodesiense strains KETRI2537 and STIB900 or with the monomorphic T. b. brucei strain STIB795. Importantly, DB75 showed activity superior to that of pentamidine at comparable doses in all three mouse models. Complete cures were achieved with oral dosing of the prodrug DB289 in all three models without any overt toxicity. This shows that the prodrug strategy was successful in terms of reducing toxicity and increasing efficacy and oral bioavailability.


Antiprotozoal Agents/therapeutic use , Benzamidines/therapeutic use , Prodrugs/therapeutic use , Trypanosoma brucei gambiense/drug effects , Trypanosomiasis, African/drug therapy , Administration, Oral , Animals , Antiprotozoal Agents/administration & dosage , Antiprotozoal Agents/adverse effects , Benzamidines/administration & dosage , Benzamidines/adverse effects , Female , Humans , Mice , Molecular Structure , Pentamidine/administration & dosage , Pentamidine/adverse effects , Pentamidine/therapeutic use , Prodrugs/administration & dosage , Prodrugs/adverse effects
...